.Merck trumps revenues requirements, brings up purchases overview on tough need for best medications like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Forecasts as Keytruda Sales Growth BloombergMerck Inventory: Pharma Giant Posts Tough End Results, Yet Outlook Falls Short Client's Organization DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats income and also purchases requirements surrounded by Keytruda strong point, however gives blended full-year outlook MarketWatch.